ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $904 | -100.0% | 19,600 | -58.6% | 0.00% | -80.0% |
| Q4 2021 | $3,986,000 | -38.3% | 47,400 | -33.8% | 0.01% | -37.5% |
| Q3 2021 | $6,458,000 | -85.4% | 71,600 | -84.5% | 0.01% | -85.5% |
| Q2 2021 | $44,090,000 | +167.4% | 462,400 | +219.3% | 0.06% | +161.9% |
| Q1 2021 | $16,487,000 | +25.6% | 144,800 | +52.7% | 0.02% | +50.0% |
| Q4 2020 | $13,123,000 | +281.0% | 94,800 | +74.3% | 0.01% | +100.0% |
| Q1 2016 | $3,444,000 | +1018.2% | 54,400 | +1600.0% | 0.01% | +600.0% |
| Q3 2015 | $308,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |